罕见病药物氨己烯酸片有什么副作用

(Vigabatrin) is a drug used to treat epilepsy and infantile spasms that was developed in the 1980s. The treatment was approved in the UK in 1989. On August 21, 2009, the U.S. FDA approved vigabatrin tablets (vigabatrin) as a monotherapy for pediatric patients aged 1 month to 2 years old. The potential benefits of infantile spasms outweigh the potential risk of vision loss, and as an adjuvant treatment for adult patients with refractory complex partial epilepsy (CPS).

Intractable complex partial seizures (CPS, also known as focal seizures), also known as temporal lobe seizures and psychomotor seizures, manifest partial seizures with varying degrees of consciousness impairment. Epileptic discharges originate from the medial temporal lobe or frontal lobe. The origin, diffusion route and speed are different, and the clinical manifestations can vary greatly. Special sensory or simple autonomic nervous system symptoms are often auras. Attacks originating from deep structures, such as psychotic attacks (auras), may be short-lived and cause confusion in consciousness quickly; disorders of consciousness may also begin immediately, or even simply cause disturbances in consciousness.

Vigabatrin is an anti-epileptic drug developed by Lundbeck. The active pharmaceutical ingredient of the drug is vigabatrin. Vigabatrin is an analog of γ-aminobutyric acid (GABA). It can specifically bind to GABA aminotransferase and irreversibly, resulting in an increase in the concentration of GABA in the brain, thereby exerting an anti-epileptic effect.

What are the side effects of the rare disease drug vigabatrin tablets?

Taking vigabatrin tablets (vigabatrin) for treatment will also produce certain side effects or adverse reactions, common ones include: fatigue/drowsiness/headache/dizziness/mental confusion/depression, etc. Before receiving treatment with vigabatrin, patients should go to the hospital for a detailed examination and strictly take medication according to the doctor's diagnosis and treatment recommendations.

The above is the introduction about (vigabatrin), I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/82917.html